Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Samama

Showing results (11-20 of 184) with videos related to

Pageof 19
Sort By:
Clinics in Laboratory Medicine|March 1, 1995
Laboratory monitoring of unfractionated heparin treatmentM M Samama
Journal Des Maladies Vasculaires|January 1, 1994
[A new cause of hereditary thrombophilia: activated protein c resistance]M M Samama
Journal of Thrombosis and Haemostasis : JTH|February 13, 2013
Which test to use to measure the anticoagulant effect of rivaroxaban: the anti-factor Xa assayM M Samama
Seminars in Thrombosis and Hemostasis|April 1, 1987
Deep vein thrombosis of inferior limbs: are thrombolytic agents superior to heparin?M M Samama
La Revue Du Praticien|December 3, 1999
[Where to look for progress in antithrombotic treatments?]M M Samama
Seminars in Hematology|October 31, 2000
Assessment of treatment strategy in high-risk surgical patientsM M Samama
Advances in Experimental Medicine and Biology|January 1, 1992
Treatment of deep vein thrombosis (DVT) with low molecular weight heparins (LMWH)M M Samama
Pathophysiology of Haemostasis and Thrombosis|July 21, 2006
Pulmonary embolism: controversies in laboratory studiesM M Samama
Journal Des Maladies Vasculaires|June 30, 2001
[A century of progress. From biology to antithrombotic agents]M M Samama
The European Journal of Surgery. Supplement. : = Acta Chirurgica. Supplement|January 1, 1994
Prevention of postoperative thromboembolism in general surgery with enoxaparinM M Samama
Pageof 19

Showing results (11-20 of 184) with videos related to

Sort By:
Pageof 19
Clinics in Laboratory Medicine|March 1, 1995
Laboratory monitoring of unfractionated heparin treatmentM M Samama
Journal Des Maladies Vasculaires|January 1, 1994
[A new cause of hereditary thrombophilia: activated protein c resistance]M M Samama
Journal of Thrombosis and Haemostasis : JTH|February 13, 2013
Which test to use to measure the anticoagulant effect of rivaroxaban: the anti-factor Xa assayM M Samama
Seminars in Thrombosis and Hemostasis|April 1, 1987
Deep vein thrombosis of inferior limbs: are thrombolytic agents superior to heparin?M M Samama
La Revue Du Praticien|December 3, 1999
[Where to look for progress in antithrombotic treatments?]M M Samama
Seminars in Hematology|October 31, 2000
Assessment of treatment strategy in high-risk surgical patientsM M Samama
Advances in Experimental Medicine and Biology|January 1, 1992
Treatment of deep vein thrombosis (DVT) with low molecular weight heparins (LMWH)M M Samama
Pathophysiology of Haemostasis and Thrombosis|July 21, 2006
Pulmonary embolism: controversies in laboratory studiesM M Samama
Journal Des Maladies Vasculaires|June 30, 2001
[A century of progress. From biology to antithrombotic agents]M M Samama
The European Journal of Surgery. Supplement. : = Acta Chirurgica. Supplement|January 1, 1994
Prevention of postoperative thromboembolism in general surgery with enoxaparinM M Samama
Pageof 19